The Technical Analyst
BrightSphere Investment [BSA]
Exchange: NYSE Sector: Industrials
BrightSphere Investment Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.04% $25.26
America/New_York / 31 des 1970 @ 19:00
| RATING 2022-02-09 |
|---|
| A+ |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | |||||
|---|---|---|---|---|---|
| 4/19 | 3/20 | 4/20 | 2/21 | 3/21 | |
| Revenue | n/a | n/a | n/a | ||
| Gr.Profit | n/a | n/a | n/a | ||
| Ebit | n/a | n/a | n/a | ||
| Asset | n/a | n/a | n/a | ||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 26.24 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 25.17 - 25.36 ( +/- 0.38%) |
| ATR Model: 14 days |
Forecast:
01:40 - $25.04
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $25.26 (-0.04% ) |
| Volume | 0.0132 mill |
| Avg. Vol. | 0.0120 mill |
| % of Avg. Vol | 110.20 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BSA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
Latest News
2020-08-19 09:49:18 - seekingalpha.com
Tracking John Paulson's Paulson & Company Portfolio - Q2 2020 Update
John Paulson’s 13F portfolio value increased from $2.62B to $3.13B this quarter. Paulson & Company's largest three positions are Bausch Health, Horizon Therapeutics, and SPDR Gold ETF.